Industry vs. FDA Regarding DTC Animation Study: Claims It’s Unnecessary & Unscientific

This article summarizes several comments submitted to the FDA in response to the agency's proposed study of animation in direct-to-consumer drug ads.

Patients with Chronic Conditions Are OK With Off-Label Drug Promotion: If FDA Allows It,...

This article summarizes the results of three surveys, which were presented at an FDA Part 15 hearing regarding 'Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products.'

Pharma Marketing News Vol. 15, Issue No. 5: December 2016

Welcome to Vol. 15, Issue No. 5 (December 2016) of Pharma Marketing News. This issue focuses on animation in DTC ads, off-label DCTC advertising, and pharma's use of Instagram.

FDA Compliant Diclegis Instagram Promo by (Good) Emily Maynard Johnson Can’t Compete with (Bad)...

About 22 weeks ago, Emily Maynard Johnson, who appeared on ABC's The Bachelor and The Bachelorette, posted the following Diclegis promotion to her Instagram...

PinUp: SM & Apps Soon Best for Marketing to Docs, IoT Opportunities, Trump v....

Welcome to the November 29, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

PinUp: Pfizer’s mBC Digital Disruption Challenge, Dark Web & Illegal Drugs, Wearable Security, More…

Welcome to the November 22, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

PinUp: FDA to Study Links, Where Docs Get Info, Path to Off-Label Promotion, More…

Welcome to the November 15, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

The Evolution of the Written Word in the Social Media Information Age

I started writing about the drug industry – specifically the commercial side of the industry – in 2002 with the publication of the first...

FDA Hears Results of Two Different Off-Label Surveys of Consumers at Recent Public Hearing

At the recent Part 15 FDA hearing on off-label promotion (see here) results from two different consumer/patient surveys were presented. The first was presented...

What is “Truthful and Non-misleading?” That is the Question FDA Must Answer to Allow...

Yesterday, I attended and presented at FDA's Public Hearing on drug company communications regarding unapproved uses of drugs. My presentation had to do with...